QHC Letters Preview Final Guidance; “Read Them,” Stresses Schneeman
This article was originally published in The Tan Sheet
FDA's letters of enforcement discretion offer industry a rough draft of the agency's upcoming final guidance on health claim substantiation, according to the Center for Food Safety & Nutrition's Barbara Schneeman, PhD
You may also be interested in...
"Scientific conclusions from observational studies cannot be drawn about a relationship between a food component and a disease," FDA concludes in draft guidance for health claim petitioners
FDA should study consumer perceptions of qualified health claims by testing statements that contain both "report card" grades and text ratings, as well as claims that do not bear a letter grade, the Consumer Healthcare Products Association says in recent comments to the agency
American Longevity will file a lawsuit against FDA no later than Dec. 9 in response to the agency's denial of qualified health claims tying lycopene-containing dietary supplements to cancer risk reduction